[HTML][HTML] The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta …
L Haigh, C Kirk, K El Gendy, J Gallacher, L Errington… - Clinical Nutrition, 2022 - Elsevier
Background & aims Lifestyle interventions that focus on reduced energy intake and
improved dietary pattern are the mainstay of non-alcoholic fatty liver disease (NAFLD) …
improved dietary pattern are the mainstay of non-alcoholic fatty liver disease (NAFLD) …
[HTML][HTML] Management of metabolic-associated fatty liver disease: The diabetology perspective
MS Jeeyavudeen, SKA Khan, S Fouda… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The metabolic syndrome as a consequence of the obesity pandemic resulted in a
substantial increase in the prevalence of metabolic-associated fatty live disease (MAFLD) …
substantial increase in the prevalence of metabolic-associated fatty live disease (MAFLD) …
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank
P He, Y Zhang, Z Ye, H Li, M Liu, C Zhou, S Yang… - Metabolism, 2023 - Elsevier
Background The association of a healthy lifestyle and the American Heart Association (AHA)
Life's Essential 8 (LE8) score with the risk of new-onset nonalcoholic fatty liver disease …
Life's Essential 8 (LE8) score with the risk of new-onset nonalcoholic fatty liver disease …
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
European Association for the Study of the Liver (EASL)… - Obesity Facts, 2024 - karger.com
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …
[HTML][HTML] Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …
E Roeb, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …
[HTML][HTML] American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease
Conclusions: The panel found consistent and compelling evidence that regular physical
activity plays an important role in preventing NAFLD and improving intermediate clinical …
activity plays an important role in preventing NAFLD and improving intermediate clinical …
[PDF][PDF] Physical activity and nonalcoholic fatty liver disease: A roundtable statement from the American College of Sports Medicine
Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the
American College of Sports Medicine Page 1 Physical Activity and Nonalcoholic Fatty Liver …
American College of Sports Medicine Page 1 Physical Activity and Nonalcoholic Fatty Liver …
[HTML][HTML] NLRP3 inflammasome in digestive diseases: from mechanism to therapy
R Qiang, Y Li, X Dai, W Lv - Frontiers in Immunology, 2022 - frontiersin.org
Digestive system diseases remain a formidable challenge to human health. NOD-like
receptor family pyrin domain containing 3 (NLRP3) inflammasome is the most characteristic …
receptor family pyrin domain containing 3 (NLRP3) inflammasome is the most characteristic …
[HTML][HTML] Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in …
RO Moreira, CM Valerio… - … of Endocrinology and …, 2023 - SciELO Brasil
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously
known as Nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic …
known as Nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic …
Non-alcoholic fatty liver disease: Current therapeutic options
A Majumdar, J Verbeek, EA Tsochatzis - Current Opinion in Pharmacology, 2021 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
and has an estimated global prevalence of 25%. NAFLD is found in up to 80% of people …
and has an estimated global prevalence of 25%. NAFLD is found in up to 80% of people …